How big is eHealth, Inc.?

As of Jun 18, eHealth, Inc. has a market capitalization of 171.75 million, with net sales of 552.57 million and a net profit of 28.99 million for the latest four quarters. The balance sheet as of December 2024 shows shareholder's funds of 925.94 million and total assets of 1,367.44 million.

As of Jun 18, eHealth, Inc. has a market capitalization of 171.75 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 552.57 million and a net profit of 28.99 million for the latest four quarters ending in March 2025, December 2024, September 2024, and June 2024.<BR><BR>As of December 2024, the balance sheet shows shareholder's funds of 925.94 million and total assets of 1,367.44 million.

What does eHealth, Inc. do?

eHealth, Inc. is a micro-cap company that offers an online platform for health insurance for individuals, families, and small businesses. As of March 2025, it reported net sales of $113 million and a net profit of $2 million.

Overview: <BR>eHealth, Inc. provides a private online source of health insurance for individuals, families, and small businesses in the insurance industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 113 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 171.75 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 6.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 3.46% <BR>Price to Book: 0.18<BR><BR>Contact Details: <BR>Address: 2625 Augustine Dr Fl 2, SANTA CLARA CA: 95054-2902 <BR>Tel: ['1 650 5842700', '1 650 2103111'] <BR>Fax: 1 302 6555049 <BR>Website: https://www.ehealthinsurance.com/

Should I buy, sell or hold eHealth, Inc.?

Who are in the management team of eHealth, Inc.?

As of March 2022, the management team of eHealth, Inc. includes CEO Scott Flanders and Lead Independent Director Jack Oliver, along with independent directors Andrea Brimmer, Beth Brooke-Marciniak, Michael Goldberg, and Randall Livingston.

As of March 2022, the management team of eHealth, Inc. includes Mr. Scott Flanders, who serves as the Chief Executive Officer and Director. Additionally, the Board of Directors features Mr. Jack Oliver as the Lead Independent Director, along with independent directors Ms. Andrea Brimmer, Ms. Beth Brooke-Marciniak, Mr. Michael Goldberg, and Mr. Randall Livingston.

Is eHealth, Inc. technically bullish or bearish?

As of September 12, 2025, eHealth, Inc. is in a mildly bearish trend, with daily moving averages and Bollinger Bands indicating bearish momentum, despite some mild bullish signals from the MACD and KST, and it has significantly underperformed the S&P 500 with a year-to-date return of -57.87%.

As of 12 September 2025, the technical trend for eHealth, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating bearish momentum and weekly Bollinger Bands showing a bearish signal. While the MACD is mildly bullish on both weekly and monthly time frames, it is countered by the overall bearish signals from the moving averages and Bollinger Bands. The KST shows mild bullishness on the weekly and bullishness on the monthly, but the Dow Theory indicates no trend in both time frames. <BR><BR>In terms of performance, eHealth has underperformed the S&P 500 significantly across multiple periods, with a year-to-date return of -57.87% compared to the S&P 500's 12.22%, and a 5-year return of -94.99% versus the S&P 500's 96.61%.

Is eHealth, Inc. overvalued or undervalued?

As of October 31, 2025, eHealth, Inc. is considered very attractive due to its undervaluation indicated by a low P/E ratio of 6, a price-to-book value of 0.20, and an EV to EBITDA ratio of 0.40, making it a compelling investment compared to its peer Abacus Life, Inc., despite its recent stock performance lagging behind the S&P 500.

As of 31 October 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 6, a price-to-book value of 0.20, and an EV to EBITDA ratio of 0.40, all of which suggest that the stock is trading at a significant discount relative to its earnings and assets. <BR><BR>In comparison to its peer, Abacus Life, Inc., which has a much higher P/E ratio of 164.30 and an EV to EBITDA of 18.86, eHealth, Inc. stands out as a more compelling investment opportunity. Additionally, the PEG ratio of 0.02 further emphasizes its undervaluation relative to growth expectations. However, it is worth noting that eHealth's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -47.55% compared to the index's 16.30%, although it has shown a positive return of 1.44% over the past year.